These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18025624)

  • 1. Intravenous methylprednisolone pulse therapy for acute posterior segment uveitis attacks in Behçet's disease.
    Yalçindag FN; Can E; Ozdemir O
    Ann Ophthalmol (Skokie); 2007; 39(3):194-7. PubMed ID: 18025624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease.
    Toker E; Kazokoğlu H; Acar N
    Br J Ophthalmol; 2002 May; 86(5):521-3. PubMed ID: 11973245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term remission of ocular and extraocular manifestations in Behçet's disease using infliximab.
    Handa T; Tsunekawa H; Yoneda M; Watanabe D; Mukai T; Yamamura M; Iwaki M; Zako M
    Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S58-63. PubMed ID: 21968238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single infliximab infusion vs corticosteroids for acute panuveitis attacks in Behçet's disease: a comparative 4-week study.
    Markomichelakis N; Delicha E; Masselos S; Fragiadaki K; Kaklamanis P; Sfikakis PP
    Rheumatology (Oxford); 2011 Mar; 50(3):593-7. PubMed ID: 21097877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10 years.
    Davatchi F; Sadeghi Abdollahi B; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Faezi T; Akhlaghi M; Ghodsi Z; Ashofteh F; Mohtasham N
    Int J Rheum Dis; 2014 May; 17(4):444-52. PubMed ID: 24314325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate in ocular manifestations of Behcet's disease: a longitudinal study up to 15 years.
    Davatchi F; Shams H; Shahram F; Nadji A; Chams-Davatchi C; Sadeghi Abdollahi B; Faezi T; Akhlaghi M; Ashofteh F
    Int J Rheum Dis; 2013 Oct; 16(5):568-77. PubMed ID: 24164845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab in the treatment of posterior uveitis in Behçet's disease. Long term follow up in four patients.
    Lanthier N; Parc C; Scavennec R; Dhôte R; Brézin AP; Guillevin L
    Presse Med; 2005 Jul; 34(13):916-8. PubMed ID: 16142147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intravenous corticosteroid megadose treatment in ocular Behçet disease].
    Postelmans L; Verougstraete C; Libert J; Efira A; Caspers-Velu L
    Bull Soc Belge Ophtalmol; 1996; 262():95-103. PubMed ID: 9376926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MONTHLY INTRAVITREAL INFLIXIMAB IN BEHÇET'S DISEASE ACTIVE POSTERIOR UVEITIS: A Long-Term Safety Study.
    Refaat M; Abdullatif AM; Hamza MM; Macky TA; El-Agha MH; Ragab G; Soliman MM
    Retina; 2021 Aug; 41(8):1739-1747. PubMed ID: 33394998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y; Oge I; Erkan D; Aritürk N; Mohajeri F
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.
    Kötter I; Zierhut M; Eckstein AK; Vonthein R; Ness T; Günaydin I; Grimbacher B; Blaschke S; Meyer-Riemann W; Peter HH; Stübiger N
    Br J Ophthalmol; 2003 Apr; 87(4):423-31. PubMed ID: 12642304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of a single dose of infliximab in the treatment of Behçet's disease uveitis.
    Arayssi T; Hamra R; Homeidan F; Uthman I; Awwad ST; Mroue K; Mansour W; Bashshur ZF
    Clin Exp Rheumatol; 2005; 23(3):427. PubMed ID: 15971438
    [No Abstract]   [Full Text] [Related]  

  • 14. Azathioprine and low dose pulse cyclophosphamide in severe ocular lesions of Behçet's disease. A preliminary report.
    Shahram F; Davatchi F; Chams H; Nadji A; Jamshidi A; Akbarian M; Gharibdoost F
    Adv Exp Med Biol; 2003; 528():571-3. PubMed ID: 12918767
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis.
    Wakefield D; Jennings A; McCluskey PJ
    Clin Exp Ophthalmol; 2000 Apr; 28(2):103-6. PubMed ID: 10933772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bolus of cyclophosphamide and methylprednisolone in uveitis in Behçet's disease. Preliminary results with the use of new criteria of evaluation].
    Hamza M; Meddeb S; Mili I; Ouertani A
    Ann Med Interne (Paris); 1992; 143(7):438-41. PubMed ID: 1300863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular Manifestations and Visual Outcomes of Behçet's Uveitis in a Thai population.
    Pathanapitoon K; Kunavisarut P; Saravuttikul FA; Rothova A
    Ocul Immunol Inflamm; 2019; 27(1):2-6. PubMed ID: 29020486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.
    Niccoli L; Nannini C; Benucci M; Chindamo D; Cassarà E; Salvarani C; Cimino L; Gini G; Lenzetti I; Cantini F
    Rheumatology (Oxford); 2007 Jul; 46(7):1161-4. PubMed ID: 17478466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease.
    Wechsler B; Bodaghi B; Huong DL; Fardeau C; Amoura Z; Cassoux N; Piette JC; LeHoang P
    Ocul Immunol Inflamm; 2000 Dec; 8(4):293-301. PubMed ID: 11262659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose intravenous 'pulse' methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study.
    Mignogna MD; Lo Muzio L; Ruoppo E; Fedele S; Lo Russo L; Bucci E
    J Oral Pathol Med; 2002 Jul; 31(6):339-44. PubMed ID: 12201245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.